Hiday Hidaka Corp.
Fiscal Year Ending February 2027 Q2 (Interim) Financial Summary [Japanese GAAP] (Non-consolidated)
Interim net sales were 34,063 million yen, up 10.8% year-over-year. Operating income was 4,067 million yen, ordinary income was 4,099 million yen, and interim net income was 2,774 million yen, all reaching record highs. Full-year forecasts for 2027 remain unchanged, and dividend guidance is unchanged from the prior period, with an interim and year-end dividend of 28 yen.
Key Figures
- Net Sales: 34,063 million yen (Year-over-Year 10.8% increase)
- Operating Income: 4,067 million yen (Year-over-Year 11.0% increase)
- Interim Net Income: 2,774 million yen (Year-over-Year 11.4% increase)
AI要約
Performance Overview
Hiday Hidaka Corp. recorded net sales of 34,063 million yen, operating income of 4,067 million yen, ordinary income of 4,099 million yen, and interim net income of 2,774 million yen for the second quarter (interim) of the fiscal year ending February 2027, all exceeding the prior year and reaching record highs. Increased sales of pharmaceuticals, promotion of DX initiatives, new store openings, and the effectiveness of promotional campaigns contributed to the results. The full-year forecast remains unchanged from the time of announcement.
Financial Position and Dividends
Total assets stood at 36,458 million yen, net assets at 26,647 million yen, and the equity ratio was 73.1%. There has been no revision to the most recently announced dividend forecast, with a year-end dividend of 28 yen indicated. Increases in cash and deposits and accounts receivable were the primary drivers of asset growth.
Hiday Hidaka Corp.
Company overview · Stock price · Financial data · All IR
